These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 26543)

  • 21. Potential molecular targets mediating chemical teratogenesis: in vitro peroxidase-catalyzed phenytoin metabolism and oxidative damage to proteins and lipids in murine maternal hepatic microsomes and embryonic 9000g supernatant.
    Liu L; Wells PG
    Toxicol Appl Pharmacol; 1995 Sep; 134(1):71-80. PubMed ID: 7676459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ontogenesis of hydroxysteroid dehydrogenase activities in rat liver. Age-dependent development and sex differentiation in the cytosol and microsomes].
    Hoff HG; Ghraf R; Raible M; Schriefers H
    Hoppe Seylers Z Physiol Chem; 1973 Mar; 354(3):306-11. PubMed ID: 4803474
    [No Abstract]   [Full Text] [Related]  

  • 23. Sex-related differences in drug-metabolizing enzyme activity of rats in carrageenan-induced inflammation.
    Ishikawa M; Sasaki K; Shiba Y; Ozaki M; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1990 Aug; 69(2):229-32. PubMed ID: 2396049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes in phenylalanine hydroxylase activity in albino rat liver during the postnatal period].
    Khodorovskaia ED; Akopian ZhI
    Vopr Med Khim; 1968; 14(6):628-31. PubMed ID: 5733704
    [No Abstract]   [Full Text] [Related]  

  • 25. Metabolism of phenytoin in teratogenesis-susceptible and -resistant strains of mice.
    Hansen DK; Hodes ME
    Drug Metab Dispos; 1983; 11(1):21-4. PubMed ID: 6132790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of N-nitrosodimethylamine demethylase in rat liver and kidney.
    Hong JY; Pan JM; Dong ZG; Ning SM; Yang CS
    Cancer Res; 1987 Nov; 47(22):5948-53. PubMed ID: 3664497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of drugs on hepatic drug metabolism in the fetus and newborn.
    Feuer G; Liscio A
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jan; 3(1):30-3. PubMed ID: 4314849
    [No Abstract]   [Full Text] [Related]  

  • 28. Cytochrome P-450-mediated covalent binding of hexachlorophene to rat tissue proteins.
    Miller A; Henderson MC; Buhler DR
    Mol Pharmacol; 1978 Mar; 14(2):323-6. PubMed ID: 642931
    [No Abstract]   [Full Text] [Related]  

  • 29. Decreases in phenytoin hydroxylation activities catalyzed by liver microsomal cytochrome P450 enzymes in phenytoin-treated rats.
    Yamazaki H; Komatsu T; Takemoto K; Saeki M; Minami Y; Kawaguchi Y; Shimada N; Nakajima M; Yokoi T
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):427-34. PubMed ID: 11259327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex-related differences in doxapram-induced alteration of drug action in the rat.
    Ishikawa M; Ozaki M; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1989 Sep; 65(3):397-400. PubMed ID: 2813960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benzpyrene hydroxylase activity and its induction by methylcholanthrene in Morris hepatomas, in host livers, in adult livers, and in rat liver during development.
    Watanabe M; Potter VR; Morris HP
    Cancer Res; 1970 Feb; 30(2):263-73. PubMed ID: 4314992
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative study of four hypolipidaemic agents on the activity of drug-metabolizing enzymes in rat liver microsomes.
    Fournel S; Magdalou J; Batt AM; Siest G
    Int J Clin Pharmacol Res; 1983; 3(6):431-6. PubMed ID: 6432712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of the activity of UGT1A1 throughout the development and adult life in a rat.
    Bustamante N; Cantarino MH; Arahuetes RM; Cubero FJ; Ortiz A
    Life Sci; 2006 Mar; 78(15):1688-95. PubMed ID: 16310220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The distribution and metabolism of Dilantin in non-pregnant, pregnant and fetal rats.
    Gabler WL; Falace D
    Arch Int Pharmacodyn Ther; 1970 Mar; 184(1):45-58. PubMed ID: 5452323
    [No Abstract]   [Full Text] [Related]  

  • 35. Diphenylhydantoin: disposition and effects of administration on hepatic function in guinea pigs.
    Lui EM; Ecobichon DJ
    Can J Physiol Pharmacol; 1979 May; 57(5):517-23. PubMed ID: 466578
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on the properties of an enzyme forming the glucuronide of pregnanediol and the pattern of development of steroid glucuronyltransferases in rat liver.
    Fuchs M; Rao GS; Rao ML; Breuer H
    J Steroid Biochem; 1977 Mar; 8(3):235-41. PubMed ID: 404476
    [No Abstract]   [Full Text] [Related]  

  • 37. Increased microsomal irreversible binding of phenytoin by valproic acid.
    Wang SL; Lai ML; Huang JD
    Biochem Pharmacol; 1991 Aug; 42(5):1143-4. PubMed ID: 1872899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Postnatal evolution of cholesterol 7 -hydroxylase activity in the rat].
    Van Cantfort J
    C R Acad Hebd Seances Acad Sci D; 1972 May; 274(18):2593-5. PubMed ID: 4625275
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of rat liver microsome proteins during development.
    Leoni S; Mangiantini MT; Marino M; Spagnuolo S; Trentalance A; Tullio R
    Cell Mol Biol; 1986; 32(3):247-51. PubMed ID: 3742536
    [No Abstract]   [Full Text] [Related]  

  • 40. Isolated rat hepatocytes as a model to study drug metabolism: dose-dependent metabolism of diphenylhydantoin.
    Inaba T; Umeda T; Mahon WA; Ho J; Jeejeebhoy KN
    Life Sci; 1975 Apr; 16(8):1227-32. PubMed ID: 1134191
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.